Save the Antibiotic Xenleta as a Last Resort

October 2019

Xenleta (zen-LEH-tah, lefamulin) will be the first oral and IV med in a new class of "pleuromutilin" antibiotics.

Xenleta is approved for community-acquired pneumonia and covers the common bugs...Strep pneumo, H. flu, and Mycoplasma. It will be touted as an option for resistant infections due to its unique mechanism.

But Xenleta doesn't seem more effective than other antibiotics.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

E-Cigarettes Emphasize Risks of Vaping and Help Kids and Teens Stop
Influenza Share the Latest Advice About 2019-2020 Influenza Immunizations
Practice Demystify the Ins and Outs of Compression Stockings
Anticoagulants Be Prepared to Manage Direct Oral Anticoagulants Around Surgery
Pediatrics Weigh Options for Managing Type 2 Diabetes in Kids
Contraceptives Don't Jump to the New Progestin-Only Oral Contraceptive, Slynd (Drospirenone)
Immunosuppressives Stay Alert for Safety Issues With Janus Kinase Inhibitors (Xeljanz, etc)
Vaccines Know When to Discuss HPV Vaccination With Adults Over Age 26
Antibiotics Save the Antibiotic Xenleta as a Last Resort
Medicare Be Familiar With Changes Coming to Medicare Part D in 2020
IBS Watch for Zelnorm's Return for Irritable Bowel Syndrome With Constipation
Fungal Infections Avoid Empiric Fluconazole for Candida auris

Save the Antibiotic Xenleta as a Last Resort

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents